BIONEXUS GENE LAB CORP (BGLC) Stock Price, Quote, News and Overview
NASDAQ:BGLC - Nasdaq - US0906282076 - Common Stock - Currency: USD
BGLC Quote, Performance and Key Statistics
BIONEXUS GENE LAB CORP
NASDAQ:BGLC (2/5/2025, 8:00:01 PM)
After market: 0.4 +0.02 (+4.99%)0.381
-0.02 (-5.46%)
The current stock price of BGLC is 0.381 USD. In the past month the price increased by 5.26%. In the past year, price decreased by -10.48%.
BGLC Latest News, Press Releases and Analysis
BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.
BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.
$BGLC signs teaming agreement with Protech Builders to develop Biogas Powerplants...
BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.
BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.
KUALA LUMPUR, Malaysia, Sept. 14, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC, the “Company”), an emerging biotechnology company...
BGLC Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| GWW | WW GRAINGER INC | 26.77 | 50.79B | ||
| URI | UNITED RENTALS INC | 17.07 | 48.44B | ||
| FAST | FASTENAL CO | 36.59 | 42.13B | ||
| FERG | FERGUSON ENTERPRISES INC | 19.28 | 36.59B | ||
| WSO.B | WATSCO INC -CL B | 36.83 | 21.89B | ||
| WSO | WATSCO INC | 36.63 | 21.77B | ||
| AER | AERCAP HOLDINGS NV | 8.17 | 18.32B | ||
| FTAI | FTAI AVIATION LTD | 43.64 | 11.99B | ||
| CNM | CORE & MAIN INC-CLASS A | 23.58 | 10.82B | ||
| AIT | APPLIED INDUSTRIAL TECH INC | 26.84 | 10.19B | ||
| WCC | WESCO INTERNATIONAL INC | 15.86 | 9.12B | ||
| BECN | BEACON ROOFING SUPPLY INC | 16.43 | 7.36B |
Related stock screener links
About BGLC
Company Profile
BioNexus Gene Lab Corp. is a holding company, which engages in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan. The company went IPO on 2020-03-11. The firm provides a molecular lab that is focused on the application of functional genomics to enable early detection of infectious diseases and cancers. The firm operates in the biochemical industry segment through its two Malaysian subsidiaries, MRNA Scientific Malaysia and Chemrex. MRNA Scientific Malaysia owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which the Company uses in its business. The firm's non-invasive blood screening tests analyze changes in RNA to coronavirus, dengue, human immunodeficiency virus (HIV), human papillomavirus (HPV) and the risk potentiality of cancer diseases. Chemrex is a wholesaler of industrial chemicals for the manufacture of industrial, medical, appliance, aero, automotive, mechanical and electronic industries in Asean region.
Company Info
BIONEXUS GENE LAB CORP
10-2 Tower B, Vertical Business Suite, 8 Jalan Kerinchi
KUALA LUMPUR WILAYAH PERSEKUTUAN MY
Employees: 30
Company Website: https://www.bionexusgenelab.com/
Investor Relations: http://www.bionexusgenelab.com/investor-relation
Phone: 13072416898
BGLC FAQ
What is the stock price of BGLC?
The current stock price of BGLC is 0.381 USD.
What is the symbol for BIONEXUS GENE LAB CORP stock?
The exchange symbol of BIONEXUS GENE LAB CORP is BGLC and it is listed on the Nasdaq exchange.
On which exchange is BGLC stock listed?
BGLC stock is listed on the Nasdaq exchange.
Is BGLC a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for BGLC, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of BGLC.
Does BGLC stock pay dividends?
BGLC does not pay a dividend.
What is the Price/Earnings (PE) ratio of BGLC?
BGLC does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.04).
What is the Short Interest ratio of BGLC stock?
The outstanding short interest for BGLC is 8.11% of its float.
BGLC Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to BGLC. When comparing the yearly performance of all stocks, BGLC is a bad performer in the overall market: 64.21% of all stocks are doing better.
BGLC Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BGLC. While BGLC has a great health rating, there are worries on its profitability.
BGLC Financial Highlights
Over the last trailing twelve months BGLC reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS increased by 77.85% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.57% | ||
| ROE | -10.04% | ||
| Debt/Equity | 0 |